Also known as: HSA
Cornerstone Robotics will present at the 2nd Global Health Summit in August 2026, where its CEO will deliver a keynote on the evolution of surgical robotics. The company's Sentire surgical system has secured regulatory approvals in China, the EU, and Singapore, and is now used in hospitals across Asia-Pacific and Europe.
Semaglutide and tirzepatide represent distinct GLP-1-based weight management medications with different mechanisms of action. Clinical trials show varying weight loss outcomes, while new combination therapies undergo head-to-head testing.
Enhertu combined with pertuzumab received FDA approval for first-line treatment of HER2-positive metastatic breast cancer, marking the first new treatment in a decade. Real-world data show trastuzumab deruxtecan efficacy is consistent across patient subgroups.
Drug Hunter's most-accessed resources, reviews, and case studies in 2025 reflected key trends in drug discovery, including the rise of oral macrocycles, advances in new modalities, and the shift from biologics to small molecules in immunology.
